HomeMarketsSharesCT Healthcare Trust Plc

Trade CT Healthcare Trust Plc - CTHT CFD

1.2395+3.59%
The chart shows the CTHT stock price data over the last 1 day, with a current price of 1.2395, a high of 1.1985, and a low of 1.1865.
Low: 1.1865High: 1.1985
Sellers:
0%
Buyers:
100%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.041
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02128 %
(-£4.26)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.02128%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00064 %
(-£0.13)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.00064%
Overnight funding adjustment time21:00 (UTC)
CurrencyGBP
Min traded quantity10
Margin5.00%
Stock exchangeGreat Britain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close1.2085
Open1.1865
1-Year Change-5.12%
Day's Range1.1865 - 1.1985

Trade CT Healthcare Trust Plc - CTHT

About Bellevue Healthcare Trust PLC

Bellevue Healthcare Trust plc, formerly BB Healthcare Trust plc, is a United Kingdom-based investment trust. The investment objective of the Company is to provide shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company also invests in American depositary receipts (ADRs), or convertible instruments issued by such companies and invests in, or underwrites, future equity issues by such companies. The Company invests in global healthcare industry, including companies within industries, such as pharmaceuticals, biotechnology, medical devices and equipment, healthcare insurers and facility operators, information technology (where the product or service supports, supplies or services the delivery of healthcare), drug retail, consumer healthcare and distribution. The Company's investment manager is Bellevue Asset Management (UK) Limited.

Financial summary

BRIEF: For the fiscal year ended 30 November 2021, Bellevue Healthcare Trust PLC revenues decreased 41% to £99.3M. Net income decreased 45% to £87.3M. Revenues reflect Gains on investments decrease of 40% to £98.8M, Realized Foreign Exchange G/L - Capital decrease from -£62K to -£3.8M, Other Income decrease from £134K to £0K. Net income also reflects Other expenses - Balancing value increase of 57% to £318K (expense).

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready